Extranodal NK/T Cell Lymphoma, Nasal Type Clinical Trial
Official title:
Evaluation of Safety and Efficacy of IBI318 Monotherapy for Relapsed/Refractory Extranodal NK/T Cell Lymphoma (Nasal Type), a Multicenter, Open-label Phase Ib/II Trial
The purpose of this study is to evaluate the safety and efficacy of IBI318 monotherapy for relapsed/refractory extranodal NK/T cell lymphoma (nasal type).
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05475925 -
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
|
Phase 1/Phase 2 |